Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.41
-0.1816-0.53%
Post-market: 34.410.00000.00%16:10 EDT
Volume:1K
Turnover:46.45K
Market Cap:13.76M
PE:- -
High:34.41
Open:34.24
Low:34.24
Close:34.59
52wk High:34.79
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.36
T/O Rate:0.34%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
23 mins ago

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
55 mins ago

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Yesterday

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Yesterday

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live
·
Yesterday

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

TIPRANKS
·
Yesterday

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS
·
Yesterday

CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications

Stock News
·
Yesterday

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Yesterday

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Yesterday

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Yesterday

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Yesterday

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Stock News
·
Yesterday

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Yesterday

Genetic Signatures Sets Date for FY2026 Results and Investor Briefing

TIPRANKS
·
Yesterday

Can Revvity (RVTY) Turn Decentralized Prenatal Screening Into a Durable Diagnostics Advantage?

Simply Wall St.
·
Yesterday

Celltrion Seeks Korean Approval for Keytruda Biosimilar CT-P51 After Positive Trial

TIPRANKS
·
Yesterday

AMD Stock Joins Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Yesterday

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23